- Poster presentation
- Open Access
Trimethoprim sulfamethoxazole drug resistance with co resistance to extended spectrum β-lactam antibiotics among bacterial isolates from HIV patients
BMC Infectious Diseases volume 14, Article number: P57 (2014)
Trimethoprim-sulfamethoxazole (TMP-SMX) is a broad spectrum antimicrobial agent and also reduces the mortality among adults and children when used as prophylaxis against opportunistic infections in HIV infected patients. Drug resistant to TMP-SMX along with Extended spectrum β-lactamase (ESBL) production among Enterobacteriaceae is creating major therapeutic problem in clinical settings for treating the bacterial infections among HIV individuals.
TMP-SMX drug resistance among the isolates was identified using Kirby-Bauer disc diffusion method and ESBL production by combination disc method (CDM). Cefotaxime (30µg) and cefotaxime/clavulanic acid (30μg/10μg) discs were placed 20 mm apart on the agar surface. Similarly, the ceftazidime (30µg) and ceftazidime/clavulanic acid (30μg/10μg) discs were also placed. After incubating overnight at 37°C, a ≥ 5mm increase in the zone diameter was interpreted as positive for ESBL production. Statistical analysis was done using SPSS software version 15.0.
A total of 103(40 Escherichia coli, 15 Klebsiella pneumoniae, 13 Pseudomonas aeruginosa, 10 Klebsiella oxytoca, 8 Proteus mirabilis, 2 Proteus vulgaris, 11 Staphylococcus aureus, 3 Staphylococcus epidermidis and 1 Streptococcus sp.) bacterial strains were isolated from HIV patients. Among these 65(63.10%;p=0.008) isolates were resistance to TMP-SMX and only 40(38.83%;p=0.023) isolates were resistant to extended spectrum β-lactam antibiotics. Twenty nine ESBL producers from HIV patients were found to be co resistant to TMP-SMX. All ESBL producing isolates showed resistance to ceftazidime and also for ceftazidime/clavulanic acid combination.
A rapid increase in the use of prophylactic TMP-SMX might be responsible for the TMP-SMX drug resistance among opportunistic bacterial infections in HIV patients.
About this article
Cite this article
Rameshkumar, M.R., Vijaykanth, N., Vignesh, R. et al. Trimethoprim sulfamethoxazole drug resistance with co resistance to extended spectrum β-lactam antibiotics among bacterial isolates from HIV patients. BMC Infect Dis 14, P57 (2014). https://doi.org/10.1186/1471-2334-14-S3-P57
- Klebsiella Pneumoniae